Nasdaq Grants SCWorx Conditional Listing Extension, Requires Reverse Split by August 3
Summary
SCWorx received conditional approval from Nasdaq to maintain its listing, requiring shareholder approval for a reverse stock split by July 22, 2026, and execution by August 3, 2026, to regain compliance with the minimum bid price rule.
Key Events
-
Nasdaq Conditional Listing Approval
The Nasdaq Hearings Panel granted SCWorx's request to continue its listing, subject to specific conditions, following the suspension of its common stock on April 14, 2026.
-
Mandatory Reverse Stock Split
The company must obtain shareholder approval for a reverse stock split by July 22, 2026, and effect the split by August 3, 2026, to achieve a post-split price sufficient for Nasdaq compliance. This follows previous proposals for a reverse split.
-
Bid Price Compliance Deadline
SCWorx must demonstrate a closing bid price of at least $1.00 per share for a minimum of 20 consecutive trading days by August 28, 2026.
-
Risk of Permanent Delisting
Failure to satisfy these conditions by the applicable deadlines will result in the common stock being permanently delisted from Nasdaq, continuing to be quoted on the OTC Markets.
Analysis
SCWorx Corp. has received a conditional reprieve from Nasdaq, allowing it a path to regain compliance and avoid permanent delisting. This decision is critical as the company's common stock was suspended from trading on Nasdaq in April 2026 due to failing the minimum bid price rule. The conditions, which include obtaining shareholder approval for another reverse stock split by July 22, 2026, effecting the split by August 3, 2026, and then maintaining a $1.00 bid price for 20 consecutive days by August 28, 2026, are challenging but offer a defined timeline to potentially restore its Nasdaq listing. Failure to meet these deadlines will result in permanent delisting to the OTC Markets.
At the time of this filing, WORX was trading at $0.45 on OTC in the Technology sector, with a market capitalization of approximately $480.1K. The 52-week trading range was $0.26 to $147.74. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.